-
Bi-specific antisense and RNAi targeting of IGFBP-2 and IGFBP-5 as a novel treatment strategy for delaying progression and bony metastasis of prostate cancer
Read MoreProstate Cancer is the most common cause of cancer and the second leading cause of cancer death in men in North America.…